Inner Mitochondrial Membrane Peptidase 2-Like Deletion Aggravates Mitochondrial Apoptosis and Inhibits Autophagy...

Area of Science:

• Neuroscience
• Mitochondrial Biology
• Metabolic Disorders

Background:

• Hyperglycemia exacerbates ischemic brain injury, particularly in individuals with diabetes.
• Mitochondrial dysfunction and apoptosis play critical roles in neuronal damage during cerebral ischemia-reperfusion (I/R) injury.
• The specific role of inner mitochondrial membrane peptidase 2-like (Immp2l) in hyperglycemic I/R injury remains unclear.

Purpose of the Study:

• To investigate the impact of Immp2l deletion on mitochondrial apoptosis and autophagy under hyperglycemic conditions.
• To elucidate the mechanisms by which Immp2l deficiency affects brain injury in a model of hyperglycemic cerebral ischemia-reperfusion (I/R).

Main Methods:

• Middle cerebral artery occlusion (MCAO) model in wild-type and Immp2l^+/- mice under hyperglycemic and normoglycemic conditions.
• Assessment of reactive oxygen species (ROS) production, mitochondrial membrane potential (JC-1 assay), and autophagy markers (LC3II/LC3I, Beclin 1).
• Transmission electron microscopy (TEM) for examining mitochondrial ultrastructure and neuronal autophagosomes.

Main Results:

• Immp2l deficiency exacerbated brain injury under hyperglycemic conditions.
• Increased ROS production and compromised mitochondrial membrane potential were observed in Immp2l-deficient mice.
• Apoptotic cascades were induced, and mitochondrial autophagy was impaired in the absence of Immp2l.
• Immp2l deficiency worsened oxidative stress, mitochondrial dysfunction, and cell death, leading to increased brain injury.

Conclusions:

• Immp2l plays a critical role in modulating the response to hyperglycemic cerebral I/R injury.
• Immp2l deficiency contributes to increased oxidative stress, mitochondrial dysfunction, and exacerbated brain injury.
• These findings suggest Immp2l as a potential therapeutic target for mitigating diabetes-related stroke outcomes.